Avanos Medical, Inc. Announces First Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall Street ends down as oil prices, Treasury yields rise
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil settles up around 4% as Iran's president vows to never surrender
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- On Holding sets 2029 financial targets, authorizes $1B share buyback
- Nasdaq reaches record high close, AI stocks rally
- Elmet Group signs tungsten offtake deal with Hemerdon Mine
- Meta bull case increasingly playing out, Mizuho says
Avanos Medical, Inc. (AVNS) Reports In-Line Q1 EPS, Maintains Guidance
May 7, 2019 7:14 AM EDTAvanos Medical, Inc. (NYSE: AVNS) reported Q1 EPS of $0.15, in-line with the analyst estimate of $0.15. Revenue for the quarter came in at $164.2 million versus the consensus estimate of $164.57 million.
The company maintains its full-year 2019 adjusted diluted earnings per share outlook of $1.15 to $1.35.... More
